Table 4.
Univariate and multivariate Cox regression analysis for predicting MACEs after PCI
Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age | 1.0296 | 1.0100–1.0495 | 0.0029 | 1.0329 | 1.0119–1.0543 | 0.0020 |
Female | 0.9596 | 0.6297–1.4624 | 0.8479 | |||
BMI | 0.9283 | 0.8696–0.9911 | 0.0258 | 0.9707 | 0.9069–1.0390 | 0.3910 |
ACS | 2.0092 | 1.0415–3.8758 | 0.0374 | 1.8754 | 0.9594–3.6659 | 0.0659 |
Smoking | 1.0485 | 0.7061–1.5569 | 0.8144 | |||
Previous PCI | 1.3494 | 0.7664–2.3759 | 0.2991 | |||
Hypertension | 1.1082 | 0.6949–1.7676 | 0.6661 | |||
SBP | 0.9963 | 0.9873–1.0053 | 0.4170 | |||
Heart rate | 1.0134 | 1.0007–1.0263 | 0.0389 | 1.0058 | 0.9925–1.0194 | 0.3928 |
BNP | 1.0003 | 1.0001–1.0005 | 0.0056 | 1.0000 | 0.9997–1.0003 | 0.9703 |
cTnT | 1.0000 | 1.0000–1.0001 | 0.5601 | |||
Scr | 1.0015 | 1.0006–1.0024 | 0.0014 | 1.0010 | 0.9999–1.0021 | 0.0782 |
HbA1c | 0.9964 | 0.8913–1.1140 | 0.9499 | |||
HDL | 1.3501 | 0.6982–2.6107 | 0.3723 | |||
LDL | 1.0502 | 0.8396–1.3136 | 0.6680 | |||
bSS | 1.0543 | 1.0350–1.0741 | < 0.001 | 1.0208 | 0.9940–1.0483 | 0.1295 |
rSS | 1.0771 | 1.0520–1.1029 | < 0.001 | 1.0406 | 1.0074–1.0750 | 0.0163 |
TyG index | 1.6053 | 1.1586–2.2243 | 0.0044 | 1.7501 | 1.2239–2.5025 | 0.0022 |
LVEF | 0.9680 | 0.9512–0.9850 | < 0.001 | 0.9758 | 0.9531–0.9989 | 0.0406 |
β-blockers | 0.7380 | 0.4887–1.1146 | 0.1487 | |||
Diuretics | 2.1210 | 1.3954–3.2238 | < 0.001 | 1.2490 | 0.7550–2.0661 | 0.3866 |
ACEI/ARB | 1.0856 | 0.7317–1.6105 | 0.6833 | |||
Insulin | 1.6609 | 1.0963–2.5163 | 0.0167 | 1.4817 | 0.9575–2.2929 | 0.0776 |
MACEs major adverse cardiac events, PCI percutaneous coronary intervention, HR hazard ratio, CI confidence interval, BMI body mass index, ACS acute coronary syndrome, SBP systolic blood pressure, BNP brain natriuretic peptide, Scr serum creatinine, HDL high density lipoprotein, LDL low density lipoprotein, bSS baseline SYNTAX score, rSS residual SYNTAX score, TyG index the triglyceride–glucose index, LVEF left ventricular ejection fraction, ACEI/ARB angiotensin converting enzyme inhibitor/angiotensin receptor blocker